Sabra Health Care REIT, Inc. Announces Third Quarter 2026 Earnings Release Date and Conference Call
Sabra Health Care REIT, Inc. Announces Third Quarter 2026 Earnings Release Date and Conference Call
Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2026 third quarter earnings release on November 2, 2026, after the close of trading.
A conference call with a simultaneous webcast to discuss the 2026 third quarter results will be held on Tuesday, November 3rd at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 833-461-5787. For participants outside the U.S., the dial-in number is 585-542-9983. The conference ID number is 325673757.
The webcast URL is https://events.q4inc.com/attendee/325673757. A digital replay of the call will be available on our website at www.sabrahealth.com.
About Sabra
Sabra Health Care REIT, Inc., a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (a "REIT") that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada.
Investor & Media Inquiries: 1-888-393-8248 or investorinquiries@sabrahealth.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20261019603264/en/
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
5 Stocks to Buy Trading at Big Discounts
2 Undervalued Stocks to Buy With Long-Term Growth Ahead
The Market May Be Too Pessimistic About This 4-Star Dividend Stock
4 Stocks to Buy for the Long-Term While They’re Still Undervalued
United States